Abstract
This work aims to investigate the possible inhibitory action of β-hydroxybutyrate (βOHB) against hematological alterations and hepatic injury associated with oxidative stress caused by D-galactose or γ-irradiation in rats. Six groups of male rats were used as the control, irradiated group (5 Gy), D-galactose (150 mg/kg b.wt), β-hydroxybutyrate (72.8 mg/kg b.wt), γ-irradiation plus βOHB, and D-galactose plus βOHB. Complete blood count and glucose-6-phosphate-dehydrogenase (G6PD) activity were determined in whole-blood samples. In addition, the hepatic malondialdehyde (MDA), nitric oxide (NO), and glutathione (GSH) levels and the superoxide dismutase (SOD) activity were evaluated. Moreover, certain elements were measured in liver tissue (iron (Fe), copper (Cu), and zinc (Zn)). The G6PD activity significantly diminished post exposure to D-galactose or γ-irradiation. In the βOHB, D-galactose, or γ-irradiation groups, liver MDA levels and SOD activity were significantly increased. Meanwhile, NO and GSH levels were significantly increased relative to normal control levels in the γ-irradiation group. The findings showed that βOHB alleviated hematological alterations, enhanced the altered biochemical indices, and modulated the change in Cu, Fe, and Zn elements in D-galactose or γ-irradiation group. These results highlight the role of βOHB as a powerful protective agent against hematological alterations and liver impairment by reducing G6PD-mediated oxidative stress and controlling the measured elements.